rs776872913
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 3P and 3B. PM1PP2BP4_ModerateBP6
The NM_000527.5(LDLR):c.434T>C(p.Val145Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | c.434T>C | p.Val145Ala | missense_variant | Exon 4 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | c.434T>C | p.Val145Ala | missense_variant | Exon 4 of 18 | 1 | NM_000527.5 | ENSP00000454071.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152204Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251190 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461582Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 34AN XY: 727120 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:1Benign:2
- -
- -
This missense variant replaces valine with alanine at codon 145 of the LDLR protein. This variant is also known as p.Val124Ala in the mature protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with familial hypercholesterolemia (PMID: 16250003) as well as in six individuals showing LDL-C levels not significantly higher than control individuals (Hartgers 2020 dissertation, Univ. Amsterdam). This variant has been identified in 5/282590 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Although there is no indication this variant causes disease, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.V145A variant (also known as c.434T>C), located in coding exon 4 of the LDLR gene, results from a T to C substitution at nucleotide position 434. The valine at codon 145 is replaced by alanine, an amino acid with similar properties. This variant has been reported in a familial hypercholesterolemia (FH) cohort, but clinical details were limited (Fouchier SW et al. Hum Mutat, 2005 Dec;26:550-6). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Familial hypercholesterolemia Uncertain:1
This missense variant replaces valine with alanine at codon 145 of the LDLR protein. This variant is also known as p.Val124Ala in the mature protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with familial hypercholesterolemia (PMID: 16250003) as well as in six individuals showing LDL-C levels not significantly higher than control individuals (Hartgers 2020 dissertation, Univ. Amsterdam). This variant has been identified in 5/282590 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Although there is no indication this variant causes disease, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at